Countries in Latin America “are bracing this year for a particularly virulent outbreak of the mosquito-borne tropical disease” known as dengue fever, after reports show an increase in the number of cases recorded this year, Agence France-Presse reports. “The Pan-American Health Organization (PAHO) said so far it has logged some 146,000 cases in the first three months of the year, of which 79 have been fatal. This time last year there were some 79,000 cases of dengue reported, with 26 deaths,” the news service writes.
Also In Global Health News: Halted WFP Operations In Somalia; India Food Security; Dengue In Puerto Rico; MDR-TB In Peru
Militants In Somalia Demand WFP Halt Operations “Somalia’s Islamist al-Shabaab militia ordered the World Food Programme [WFP] to halt operations in the country, accusing the United Nations agency of undermining domestic agriculture and supporting foreign troops,” Bloomberg/BusinessWeek reports (Omar, 3/1). “Even in the best years, arid Somalia is only able…
By rendering female Aedes aegypti mosquitoes â€“ the dengue virus vector â€“ unable to fly, scientists say they may be able to slow the spread of the virus which experts believe “affects up to 100 million people a year and threatens over a third of the world’s population,” the BBC reports. Currently, there is no treatment for dengue nor a vaccine to protect against the virus.
Also In Global Health News: GSK’s Interest In NTDs; Kenya’s Male Circumcision Drive; Dengue Fever; HIV Prevention In Jamaica; Food Shortages In Zimbabwe
GSK Head Discusses Company Interest In NTDs The Associated Press features a Q&A with GlaxoSmithKline (GSK) CEO Andrew Witty, who “is pushing to sell more products in fast-growing ‘emerging markets’ such as Brazil, Russia, India and China” while simultaneously “increasing efforts to bring medicines for tropical diseases to the poorest…
Also In Global Health News: Dengue Vaccine; Medicines For Poor; Gates New Ag Development Director; USDA Efforts In Afghanistan; Soccer And Malaria
Experimental Dengue Vaccine Shows Promise In Clinical Trial Of Adults An experimental dengue vaccine created by the drugmaker Sanofi-Aventis protected a group of healthy adults from all four strains of the virus, “bringing the drugmaker closer to providing the first vaccine against a disease that threatens 40 percent of the…
Dengue is the “fastest growing” vector-borne disease worldwide, NBC News’ “World Blog” writes in a story examining the disease.
Also In Global Health News: Kenya Child Mortality; DRC Rape; Cape Verde Dengue Outbreak; Guatemala Malnutrition; East Africa Flooding
Child Mortality In Kenya Still High, Survey Shows “The most current data from the Kenya National Bureau of Statistics under the Demographic and Health Survey (DHS) launched on Wednesday shows mortality among children under five years stands at 7.4 percent, while that of infants is at 5.2 percent,” Business Daily…
Lancet Infectious Diseases Review Examines Progress On Dengue Vaccine “The spread of dengue virus throughout the tropics represents a major, rapidly growing public health problem with an estimated 2.5 billion people at risk of dengue fever and the life-threatening disease, severe dengue,” write the authors of a Lancet Infectious Diseases…
At its general assembly in New Delhi, India, the World Medical Association (WMA), “a conglomerate of medical associations around the world,” approved a plan that aims “to minimise the risk of increased malnutrition deaths, diseases and injuries due to climate change,” IANS/Thaindian News reports (10/17).
Associated Press/Washington Post Examine Contributions Of Military Research To Reducing Global Disease Burden
In light of the U.S. Army’s announcement yesterday that an experimental HIV vaccine trial it is sponsoring in Thailand showed modest potential for preventing infection, the Associated Press/Washington Post examines how military research is contributing to the fight against major diseases around the world.